I’m Aware That I’m Rare : Catherine Falardeau (370)
The phaware® interview
In this episode, scleroderma patient, Catherine Falardeau, discusses her road to diagnosis and how a right heart catheterization, led to also being diagnosed with PAH, ILD, Raynaud’s, and Pulmonary Fibrosis. Catherine recently participated in a 108 week clinical trial for the use of TYVASO® in PAH/ILD patients. The trial lasted into Covid, and received FDA approval.